Arrive AI Inc. (ARAI): Nasdaq/NYSE listing notice — Arrive AI receives Nasdaq deficiency notice for bid price below $1.00; 180-day cure period until Nov 30, 2026

Arrive AI Inc.

Deficiency letter received June 2, 2026 for failing to maintain minimum bid price of $1.00 over 30 consecutive business days.
Compliance period of 180 days expires November 30, 2026; requires closing bid >=$1.00 for 10 consecutive business days.
If not cured by deadline, may qualify for a second 180-day period if all other initial listing standards are met.
Company will monitor and evaluate options but cannot assure compliance or avoid eventual delisting.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Arrive AI Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5450(a)(1)

Exact text from the filing

June 2, 2026, Arrive AI Inc. (the “Company”) received a deficiency letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, based upon the closing bid price of the Company’s common stock, par value $0.0002 per share (the “Common Stock”), for the last 30 consecutive business days, the Company is not currently in compliance with the requirement to maintain a minimum bid price of $1.00 per share for continued listing on The Nasdaq Global Market, as set forth in Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Price Requ

View on SEC.gov

Browse all listing & compliance notices →

Arrive AI Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-027491

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.